EIF4E and breast carcinoma: Mnk has emerged as an exciting and promising strategy for cancer therapy, for example, degradation of Mnk1 blocks eIF4E phosphorylation and subsequently inhibits cell growth, colonization, invasion, migration and induces apoptosis in triple negative and HER2-overexpressing breast cancer cell lines [28].